MV Capital Management’s Nomura Holdings NMR Stock Holding History

MV Capital Management’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85K	Sell	211 -8	-4%	-$67	﹤0.01%	806
2026 Q1	$1.73K	Buy	219 +169	+338%	+$1.46K	﹤0.01%	771
2025 Q4	$420	Buy	+50	New	+$373	﹤0.01%	940

Other funds holding NMR

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MV Capital Management's NMR Position: Q2 2026 in Review

MV Capital Management reduced its Nomura Holdings (NMR) stake by 3.7% in Q2 2026, selling an estimated $67 and leaving 211 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

MV Capital Management first reported a position in NMR in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

MV Capital Management held 211 shares of Nomura Holdings worth $1.85K as of Q2 2026.
MV Capital Management sold 8 Nomura Holdings shares in Q2 2026, an estimated $67.
Nomura Holdings made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #806 holding.
MV Capital Management first reported a position in Nomura Holdings in Q4 2025 and has held it in 3 quarters since.
300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.